Neogen Chemicals EGM Resolution Passes with Overwhelming 99.99% Shareholder Approval

2 min read     Updated on 31 Mar 2026, 02:08 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Neogen Chemicals successfully concluded its extraordinary general meeting on March 29, 2026, with shareholders providing overwhelming support of 99.99% approval for the preferential issuance of equity shares to promoter group members. The meeting, conducted through video conferencing, saw participation from 88 shareholders and recorded over 2.04 crore votes through remote e-voting and e-voting during the meeting, representing 77.39% of outstanding shares.

powered bylight_fuzz_icon
36327201

*this image is generated using AI for illustrative purposes only.

Neogen chemicals conducted an extraordinary general meeting on March 29, 2026, to deliberate on the preferential issuance of equity shares to its promoter group members. The meeting concluded with overwhelming shareholder support, as the resolution received 99.99% approval from voting members.

Meeting Structure and Participation

The EGM commenced at 11:30 a.m. IST and concluded efficiently at 11:56 a.m. IST under the chairmanship of Mr. Anurag Surana, Chairman and Non-Executive Director. Company Secretary Unnati Kanani welcomed shareholders, directors, and auditors who participated through the electronic platform provided by MUFG Intime India Private Limited (formerly Link Intime India Private Limited).

Meeting Details: Information
Date: March 29, 2026
Start Time: 11:30 a.m. IST
End Time: 11:56 a.m. IST
Format: Video Conferencing/Audio-Visual Means
Chairman: Mr. Anurag Surana
Total Shareholders on Record: 55,158
Shareholders Attended via VC: 88 (15 Promoter Group, 73 Public)

Voting Results and Overwhelming Approval

The resolution for preferential equity share issuance to promoter group members secured exceptional shareholder support. CS Devendra V. Deshpande from DVD & Associates served as the appointed scrutinizer for the voting process.

Voting Summary: Details
Total Valid Votes Cast: 2,04,17,139
Votes in Favor: 2,04,17,119
Votes Against: 20
Approval Percentage: 99.9999%
Record Date: March 20, 2026

Category-wise Voting Breakdown

The voting pattern demonstrated strong support across all shareholder categories:

Shareholder Category: Votes Polled Votes in Favor Approval Rate
Promoter and Promoter Group: 1,35,12,677 1,35,12,677 100%
Public-Institutions: 62,66,630 62,66,630 100%
Public-Non Institutions: 6,37,832 6,37,812 99.9969%

E-voting Process and Timeline

The company facilitated comprehensive voting arrangements through multiple channels. Remote e-voting was available from Thursday, March 26, 2026, at 9:00 a.m. IST through Saturday, March 28, 2026, at 5:00 p.m. IST. Additionally, e-voting during the EGM was provided for members who had not participated in remote voting.

E-voting Statistics: Numbers
Remote E-voting: 1,93,15,448 votes
E-voting During EGM: 11,01,691 votes
Total E-votes: 2,04,17,139 votes
Voting Percentage of Outstanding Shares: 77.39%

Regulatory Compliance and Documentation

On March 30, 2026, the company submitted the consolidated voting results and scrutinizer's report to BSE Limited and National Stock Exchange of India Limited under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting proceedings were conducted in full compliance with regulatory requirements, with the notice dated March 7, 2026, and corrigendum dated March 17, 2026, distributed to all registered shareholders.

Resolution Details and Business Agenda

The meeting focused on a single special resolution regarding the issuance of equity shares on preferential basis to promoter group members. The resolution was deemed passed on March 29, 2026, with the requisite majority secured through the voting process.

Resolution Specifications: Details
Resolution Type: Special Business
Subject: Preferential Equity Share Issuance
Beneficiary: Promoter Group Members
Status: Passed with Requisite Majority
Scrutinizer: CS Devendra V. Deshpande (FCS 6099)

Historical Stock Returns for Neogen Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.91%+8.61%+12.84%+2.58%-7.76%+72.64%

What specific growth initiatives or expansion plans will Neogen Chemicals fund with the capital raised from this preferential share issuance?

How might this increase in promoter shareholding affect Neogen's corporate governance structure and minority shareholder influence?

Will this preferential issuance impact Neogen's eligibility for institutional investment or inclusion in key market indices?

Neogen Chemicals Publishes Newspaper Corrigendum to EGM Notice for Rs. 161 Crore Issue

3 min read     Updated on 18 Mar 2026, 01:56 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Neogen Chemicals has published mandatory newspaper advertisements regarding the corrigendum to its EGM notice scheduled for March 29, 2026, addressing stock exchange clarifications on its Rs. 161 crore preferential issue. The funds will primarily support Neogen Ionics Limited's battery materials facility with Rs. 100 crore investment, alongside Rs. 21 crore for working capital and Rs. 40 crore for general corporate purposes.

powered bylight_fuzz_icon
35295031

*this image is generated using AI for illustrative purposes only.

Neogen chemicals has published newspaper advertisements regarding the corrigendum to its Extraordinary General Meeting (EGM) notice, following the comprehensive clarifications issued in response to stock exchange queries about its proposed Rs. 161.00 crore preferential issue.

Regulatory Compliance and Publication Requirements

Pursuant to Regulation 30 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, the company published newspaper clippings in Financial Express (English Daily) and Mumbai Lakshadeep (Marathi Daily) on March 18, 2026. The advertisements provide corrigendum details for the EGM scheduled on March 29, 2026 at 11:30 a.m. (IST) through Video Conference/Other Audio-Visual Means (OAVM).

Publication Details: Information
English Daily: Financial Express
Marathi Daily: Mumbai Lakshadeep
Publication Date: March 18, 2026
Meeting Date: March 29, 2026
Meeting Time: 11:30 a.m. (IST)

The newspaper clippings have been uploaded to the company's website at https://neogenchem.com/announcements/ in the issue of securities tab, ensuring comprehensive accessibility for all stakeholders.

Enhanced Fund Utilization Details

The corrigendum provides comprehensive information on the utilization of issue proceeds totaling Rs. 161.00 crore across three key areas with specific deployment timelines:

Object: Amount (Rs. Crore) Timeline
Investment in Neogen Ionics Limited: 100.00 Within 90 days from allotment
Working capital requirements: 21.00 Within 90 days from allotment
General corporate purposes: 40.00 Within 90 days from allotment

The company has indicated that there may be variations not exceeding +/- 10% in the estimated amounts for each object. Pending utilization, proceeds will be invested in money market instruments or scheduled commercial bank deposits as permitted under applicable laws.

Neogen Ionics Limited - Battery Materials Strategy

The largest portion of funds, Rs. 100.00 crore, will be invested in Neogen Ionics Limited (NIL), a wholly-owned subsidiary incorporated on March 29, 2023. NIL focuses on battery chemicals business, particularly lithium-ion battery materials including electrolytes and lithium salts.

The subsidiary has acquired approximately 65 acres of land in Pakhajan, Dahej PCPIR, Gujarat, in December 2023 for establishing a battery materials facility. The comprehensive project includes:

  • 30,000 MTA electrolyte capacity with MUIS Technology License
  • 3,000 MTA specialty lithium electrolyte salts and additives at Pakhajan
  • Additional 2,000 MTA electrolyte capacity at Dahej SEZ
  • 2,500 MTA specialty lithium electrolyte salts/additives using indigenous technology

Project Economics and Investment Structure

Parameter: Details
Estimated Total Capex: Rs. 1,500.00 crore
Peak Revenue Potential: Rs. 2,500.00 - Rs. 2,950.00 crore
Investment Form: Equity, convertible debentures, or combination
Deployment Method: One or more tranches

Promoter Group Changes and Allottee Details

The corrigendum provides detailed information about Cadamba Solutions Private Limited, incorporated on December 15, 2025, which belongs to the promoter group and is owned by promoter Dr. Harin Kanani. Cadamba is proposed to be allotted 10,00,000 equity shares at Rs. 1,610.00 per share, representing a premium over the floor price of Rs. 1,375.82 per share.

The document details inter-se transfers of shares executed on December 31, 2025, by promoter and promoter group members to their respective family trusts pursuant to SEBI exemption order WTM/KCV/CFD/17/2025-26:

Transferor: Transferee Shares Transferred Post-Transfer Holding
Haridas Kanani: Haridas Kanani Family Trust 52,76,500 8,77,387 (3.33%)
Haridas Kanani: H T Kanani Family Trust 5,02,000 3,75,387 (1.42%)
Beena Kanani: Beena Kanani Family Trust 26,38,250 2,74,691 (1.04%)

Documentation and Compliance Framework

The company has confirmed that a certificate from DVD & Associates, Company Secretaries, certifying compliance with SEBI ICDR Regulations will be available for member inspection during the meeting and on the company website. The corrigendum emphasizes that all fund deployment will be completed within 90 days of equity share allotment.

Due to the inter-se transfers during the 90 trading days preceding the relevant date, Cadamba has made an application to SEBI pursuant to regulation 300 of SEBI ICDR regulations seeking exemption from strict application of regulation 159. The current and proposed status of Cadamba remains as promoter group member post the preferential issue.

Historical Stock Returns for Neogen Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.91%+8.61%+12.84%+2.58%-7.76%+72.64%

How will Neogen's entry into the lithium-ion battery materials market position the company against established players in India's rapidly growing EV ecosystem?

What impact could SEBI's decision on Cadamba's exemption application have on the timeline and structure of the Rs. 161 crore preferential issue?

Given the Rs. 1,500 crore total capex requirement for Neogen Ionics, what additional funding strategies might the company pursue beyond this initial Rs. 100 crore investment?

More News on Neogen Chemicals

1 Year Returns:-7.76%